Bourbon virus is an emerging tick-borne virus that belongs to the genus Thogotovirus. First identified in 2014 in Bourbon County, Kansas, the virus is transmitted to humans through tick bites, particularly those from the lone star tick (Amblyomma americanum). Bourbon virus infections are characterized by non-specific symptoms, including fever, fatigue, rash, and muscle aches. In severe cases, patients may experience nausea, vomiting, and low platelet counts. The limited number of reported cases makes it challenging to fully understand the clinical spectrum and long-term consequences of Bourbon virus infections. Diagnosing the virus involves specialized laboratory tests, including molecular and serological assays, and is often considered in individuals with a history of tick exposure and unexplained febrile illness. As there is currently no specific antiviral treatment for Bourbon virus infections, management focuses on supportive care, including the alleviation of symptoms and monitoring for complications. Prevention strategies involve avoiding tick bites through protective clothing, tick repellents, and thorough tick checks after potential exposure. Given the limited knowledge about Bourbon virus, ongoing research aims to uncover more details about its epidemiology, transmission dynamics, and potential reservoirs. Increased awareness among healthcare professionals and the public is crucial for early detection and reporting of cases, contributing to a better understanding of this emerging tick-borne pathogen.
Title : The role of the humoral innate immune system in evasion of streptococcus pyogenes infections
Francis J. Castellino, University of Notre Dame, United States
Title : Global environmental changes and mosquito-borne diseases in coastal areas
Ranjan Ramasamy, IDFISH Technology, United States
Title : The impact of global antibiotic resistance on the healthcare system, public health, environment and society
Reza Nassiri, Michigan State University, United States
Title : Current topics of adult COVID-19, Influenza, and RS virus patients in Japan
Seki Masafumi, Saitama Medical University International Medical Center, Japan
Title : Novel nanotechnology and its potential applications
Stephen Hsu, Augusta University, United States
Title : 2000 years of pandemics: Past, present and future
Claudia Ferreira, Biophytis Sorbonne, France